Provides for the initiation of treatment for COVID-19, influenza, and pharyngitis resulting from a Group A streptococcal infection by a licensed pharmacist in certain circumstances.
- Chamber
- Senate
- Introduced
- Feb 6, 2025
- Last action
- Jan 7, 2026 — REFERRED TO HIGHER EDUCATION
- Session
- 2025-2026
- Momentum
- 45 · Moderate